Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
roche
biotech
clinical trials
fda
life sciences
national blog main
national top stories
boston
boston blog main
boston top stories
deals
genentech
san francisco top stories
alexion pharmaceuticals
alnylam pharmaceuticals
atea pharmaceuticals
avapritinib
billy dunn
biogen
blueprint medicines
boehringer ingelheim
coronavirus
covid-19
cstone pharmaceuticals
dicerna pharamceuticals
drug prices
drug pricing
eli lilly
europe top stories
european medicines agency
evrysdi
fisogatinib
flatiron health
gene therapy
hepatitis b
hepatitis b virus
hepatocellular carcinoma
hereditary transthyretin amyloidosis
investing
ionis pharmaceuticals
What
drug
4
×
roche
4
×
currently
fda
intended
medicine
medicines
new
oral
pharmaceuticals
team
announced
antiviral
approval
approved
atea
atrophy
blueprint
cancer
candidate
caught
causing
coronavirus
cure
daily
deal
developme
dicerna
disease
evrysdi
eye
far
friday
gene
giant
green
groundbreaking
hepatitis
home
lights
Language
unset
Current search:
roche
×
drug
×
@bgr.com
3 years ago
This groundbreaking new coronavirus cure is unlike any other drug we’ve seen so far
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug